eperisone controlled-release (DW1030) / Daewon Pharma - LARVOL DELTA

Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203 (clinicaltrials.gov) - P1; N=0; Withdrawn; Sponsor: Navipharm Corporation; N=30 ➔ 0; Trial completion date: Dec 2017 ➔ Dec 2019; Suspended ➔ Withdrawn; Trial primary completion date: Dec 2017 ➔ Dec 2019

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal